Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Choledocholithiasis × Meperidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Pain 1 Neoplasm Metastasis 1 Choledocholithiasis 1 Choledochal Cyst 1 Cholangitis 1 Carcinoma in Situ 1 Carcinoma 1 Agnosia 1

Interventions

Midazolam 1 Meperidine 1 Ketamine 1 Duodenoscopes 1 Congresses as Topic 1 Blood Culture 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06111872 2025-03-25

Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography.

National University of Malaysia

Phase 2 Completed

Gastrointestinal

Cholangitis, Pancreatic Neoplasms, Choledochal Cyst, Choledocholithiasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡